Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Eculizumab for Pediatric Hematopoietic Cell Transplant-Associated Thrombotic Microangiopathy: Real-World Response Rates, Predictors of Poor Response, and an Optimal Time Point for Treatment Response Assessment.
Journal: Transplantation and cellular therapy
Published: March 24, 2026
Social vulnerability is not associated with reduced access to hematopoietic cell transplantation among referred pediatric patients with hematologic malignancies.
Journal: Bone marrow transplantation
Published: February 25, 2026
Validation of D-Dimer as a Prognostic Biomarker in Transplant-Associated Thrombotic Microangiopathy in Children.
Journal: Pediatric blood & cancer
Published: July 08, 2025
Endotheliopathy syndromes, TA-TMA, and SOS, are risk factors for morbidity and mortality in critically ill pediatric hematopoietic cell transplant recipients.
Journal: Frontiers in oncology
Published: June 07, 2025
Eculizumab is Associated With Increased Infection Rates and Infection Related Mortality in Children With Thrombotic Microangiopathy After HCT.
Journal: American journal of hematology
Published: May 25, 2025
Fatal thrombotic microangiopathy during induction for acute myeloid leukemia: A case report and review of vascular complications in germline GATA2 haploinsufficiency.
Journal: British journal of haematology
Published: October 02, 2024
The impact of language discordance on pediatric cancer care outcomes: A systematic review.
Journal: Pediatric blood & cancer
Published: June 30, 2024
Expanding the Spectrum of Immune Abnormalities in VICI Syndrome.
Journal: Journal of clinical immunology
Published: February 15, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026